Literature DB >> 32598950

Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.

Tiarnan D L Keenan1, Traci E Clemons2, Amitha Domalpally3, Michael J Elman4, Moshe Havilio5, Elvira Agrón6, Gidi Benyamini5, Emily Y Chew6.   

Abstract

PURPOSE: To evaluate the performance of retinal specialists in detecting retinal fluid presence in spectral domain OCT (SD-OCT) scans from eyes with age-related macular degeneration (AMD) and compare performance with an artificial intelligence algorithm.
DESIGN: Prospective comparison of retinal fluid grades from human retinal specialists and the Notal OCT Analyzer (NOA) on SD-OCT scans from 2 common devices. PARTICIPANTS: A total of 1127 eyes of 651 Age-Related Eye Disease Study 2 10-year Follow-On Study (AREDS2-10Y) participants with SD-OCT scans graded by reading center graders (as the ground truth).
METHODS: The AREDS2-10Y investigators graded each SD-OCT scan for the presence/absence of intraretinal and subretinal fluid. Separately, the same scans were graded by the NOA. MAIN OUTCOME MEASURES: Accuracy (primary), sensitivity, specificity, precision, and F1-score.
RESULTS: Of the 1127 eyes, retinal fluid was present in 32.8%. For detecting retinal fluid, the investigators had an accuracy of 0.805 (95% confidence interval [CI], 0.780-0.828), a sensitivity of 0.468 (95% CI, 0.416-0.520), a specificity of 0.970 (95% CI, 0.955-0.981). The NOA metrics were 0.851 (95% CI, 0.829-0.871), 0.822 (95% CI, 0.779-0.859), 0.865 (95% CI, 0.839-0.889), respectively. For detecting intraretinal fluid, the investigator metrics were 0.815 (95% CI, 0.792-0.837), 0.403 (95% CI, 0.349-0.459), and 0.978 (95% CI, 0.966-0.987); the NOA metrics were 0.877 (95% CI, 0.857-0.896), 0.763 (95% CI, 0.713-0.808), and 0.922 (95% CI, 0.902-0.940), respectively. For detecting subretinal fluid, the investigator metrics were 0.946 (95% CI, 0.931-0.958), 0.583 (95% CI, 0.471-0.690), and 0.973 (95% CI, 0.962-0.982); the NOA metrics were 0.863 (95% CI, 0.842-0.882), 0.940 (95% CI, 0.867-0.980), and 0.857 (95% CI, 0.835-0.877), respectively.
CONCLUSIONS: In this large and challenging sample of SD-OCT scans obtained with 2 common devices, retinal specialists had imperfect accuracy and low sensitivity in detecting retinal fluid. This was particularly true for intraretinal fluid and difficult cases (with lower fluid volumes appearing on fewer B-scans). Artificial intelligence-based detection achieved a higher level of accuracy. This software tool could assist physicians in detecting retinal fluid, which is important for diagnostic, re-treatment, and prognostic tasks. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2020        PMID: 32598950     DOI: 10.1016/j.ophtha.2020.06.038

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)-a phase III, prospective, multicentre, randomized study: design and methods.

Authors:  Leonard M Coulibaly; Stefan Sacu; Philipp Fuchs; Hrvoje Bogunovic; Georg Faustmann; Christian Unterrainer; Gregor S Reiter; Ursula Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2022-07-05       Impact factor: 4.456

2.  Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.

Authors:  Antonio Yaghy; Aaron Y Lee; Pearse A Keane; Tiarnan D L Keenan; Luisa S M Mendonca; Cecilia S Lee; Anne Marie Cairns; Joseph Carroll; Hao Chen; Julie Clark; Catherine A Cukras; Luis de Sisternes; Amitha Domalpally; Mary K Durbin; Kerry E Goetz; Felix Grassmann; Jonathan L Haines; Naoto Honda; Zhihong Jewel Hu; Christopher Mody; Luz D Orozco; Cynthia Owsley; Stephen Poor; Charles Reisman; Ramiro Ribeiro; Srinivas R Sadda; Sobha Sivaprasad; Giovanni Staurenghi; Daniel Sw Ting; Santa J Tumminia; Luca Zalunardo; Nadia K Waheed
Journal:  Exp Eye Res       Date:  2022-05-04       Impact factor: 3.770

3.  Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.

Authors:  Tiarnan D L Keenan; Usha Chakravarthy; Anat Loewenstein; Emily Y Chew; Ursula Schmidt-Erfurth
Journal:  Am J Ophthalmol       Date:  2021-02-15       Impact factor: 5.258

4.  Predicting wet age-related macular degeneration (AMD) using DARC (detecting apoptosing retinal cells) AI (artificial intelligence) technology.

Authors:  Paolo Corazza; John Maddison; Paolo Bonetti; Li Guo; Vy Luong; Alan Garfinkel; Saad Younis; Maria Francesca Cordeiro
Journal:  Expert Rev Mol Diagn       Date:  2020-12-28       Impact factor: 5.225

5.  Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda.

Authors:  Yogesh Kumar; Apeksha Koul; Ruchi Singla; Muhammad Fazal Ijaz
Journal:  J Ambient Intell Humaniz Comput       Date:  2022-01-13

6.  Artificial Intelligence, Heuristic Biases, and the Optimization of Health Outcomes: Cautionary Optimism.

Authors:  Michael Feehan; Leah A Owen; Ian M McKinnon; Margaret M DeAngelis
Journal:  J Clin Med       Date:  2021-11-14       Impact factor: 4.241

Review 7.  Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review.

Authors:  Justin C Muste; Matthew W Russell; Rishi P Singh
Journal:  Clin Ophthalmol       Date:  2021-09-02

Review 8.  Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy.

Authors:  Gregor S Reiter; Ursula Schmidt-Erfurth
Journal:  Ther Adv Ophthalmol       Date:  2022-03-23

9.  Prediction of treatment outcome in neovascular age-related macular degeneration using a novel convolutional neural network.

Authors:  Tsai-Chu Yeh; An-Chun Luo; Yu-Shan Deng; Yu-Hsien Lee; Shih-Jen Chen; Po-Han Chang; Chun-Ju Lin; Ming-Chi Tai; Yu-Bai Chou
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

10.  Validation and Clinical Applicability of Whole-Volume Automated Segmentation of Optical Coherence Tomography in Retinal Disease Using Deep Learning.

Authors:  Marc Wilson; Reena Chopra; Megan Z Wilson; Charlotte Cooper; Patricia MacWilliams; Yun Liu; Ellery Wulczyn; Daniela Florea; Cían O Hughes; Alan Karthikesalingam; Hagar Khalid; Sandra Vermeirsch; Luke Nicholson; Pearse A Keane; Konstantinos Balaskas; Christopher J Kelly
Journal:  JAMA Ophthalmol       Date:  2021-09-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.